2013-2514

Nefrología (English Edition)

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1440 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1440 DOIs
2

Attach ORCID iDs across 1253 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1253 DOIs
3

Deposit reference lists for 14 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact14 DOIs

DOIs for this ISSN

Showing the top 5 of 1440 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Dietary acid load: Mechanisms and evidence of its health rep… (10.1016/j.nefroe.2019.08.001)
Abstract ORCID
91.63 67
2 Chronic kidney disease in Spain: Prevalence and impact of ac… (10.1016/j.nefroe.2018.04.010)
Abstract ORCID
84.51 48
3 Impact of physical exercise in patients with chronic kidney… (10.1016/j.nefroe.2020.06.012)
Abstract ORCID
78.99 37
4 Information and consensus document for the detection and man… (10.1016/j.nefroe.2022.07.003)
Abstract ORCID
78.99 37
5 Gut microbiota in chronic kidney disease (10.1016/j.nefroe.2017.01.017)
Abstract ORCID
75.26 31
6 Protocol against coronavirus diseases in patients on renal r… (10.1016/j.nefroe.2020.03.010)
Abstract References ORCID
75.00 9
7 Anemia of chronic kidney disease: Protocol of study, managem… (10.1016/j.nefroe.2018.01.007)
Abstract ORCID
73.12 28
8 Status of SARS-CoV-2 infection in patients on renal replacem… (10.1016/j.nefroe.2020.04.002)
Abstract ORCID
71.57 26
9 Ferroptosis and kidney disease (10.1016/j.nefroe.2020.09.006)
Abstract ORCID
69.01 23
10 Epidemiology of hyperkalemia in chronic kidney disease (10.1016/j.nefroe.2018.11.014)
Abstract ORCID
68.09 22
11 An update for atypical haemolytic uraemic syndrome: Diagnosi… (10.1016/j.nefroe.2015.11.006)
Abstract ORCID
66.11 20
12 High prevalence of asymptomatic COVID-19 in hemodialysis. Da… (10.1016/j.nefroe.2020.06.013)
Abstract ORCID
66.11 20
13 Epidemiology, clinical profile, management, and two-year ris… (10.1016/j.nefroe.2022.01.008)
Abstract ORCID
65.05 19
14 Interleukin-17A: Potential mediator and therapeutic target i… (10.1016/j.nefroe.2021.06.003)
Abstract ORCID
63.94 18
15 Hyporesponsiveness or resistance to the action of parathyroi… (10.1016/j.nefroe.2021.11.014)
Abstract ORCID
61.52 16
16 Etiopathogenesis of chronic kidney disease-associated prurit… (10.1016/j.nefroe.2023.03.015)
Abstract ORCID
61.52 16
17 Acute kidney failure in patients admitted due to COVID-19 (10.1016/j.nefroe.2021.02.006)
Abstract ORCID
58.80 14
18 Pruritus in dialysis patients. Review and new perspectives (10.1016/j.nefroe.2022.02.004)
Abstract ORCID
58.80 14
19 Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic… (10.1016/j.nefroe.2020.04.001)
Abstract ORCID
57.31 13
20 Frailty in end stage renal disease: Current perspectives (10.1016/j.nefroe.2021.05.008)
Abstract ORCID
57.31 13
21 The neutrophil-to-lymphocyte ratio as a marker of vasculitis… (10.1016/j.nefroe.2021.07.005)
Abstract ORCID
57.31 13
22 Recommendations for living donor kidney transplantation (10.1016/j.nefroe.2022.07.001)
Abstract ORCID
57.31 13
23 CKD: The burden of disease invisible to research funders (10.1016/j.nefroe.2021.09.005)
Abstract ORCID
55.70 12
24 Mortality of hemodialysis patients is associated with their… (10.1016/j.nefroe.2021.10.006)
Abstract ORCID
55.70 12
25 The Spanish Scientific Societies before the ESC 2021 guideli… (10.1016/j.nefroe.2023.06.005)
Abstract ORCID
55.70 12
26 Finerenone: towards a holistic therapeutic approach to patie… (10.1016/j.nefroe.2023.09.002)
Abstract ORCID
55.70 12
27 The anaemia control model: Does it help nephrologists in the… (10.1016/j.nefroe.2018.10.001)
Abstract ORCID
53.96 11
28 Factors associated with the compensation of renal function a… (10.1016/j.nefroe.2018.10.002)
Abstract ORCID
53.96 11
29 Recommendations on management of the SARS-CoV-2 coronavirus… (10.1016/j.nefroe.2020.03.017)
Abstract ORCID
53.96 11
30 Antioxidant effect of p-coumaric acid on interleukin 1-β and… (10.1016/j.nefroe.2020.06.017)
Abstract ORCID
53.96 11
31 Neutrophil, lymphocyte and platelet ratio as a predictor of… (10.1016/j.nefroe.2020.09.001)
Abstract ORCID
53.96 11
32 Kidney transplant in the next decade: Strategies, challenges… (10.1016/j.nefroe.2022.04.008)
Abstract ORCID
53.96 11
33 Definition and evolution of the concept of sarcopenia (10.1016/j.nefroe.2023.08.007)
Abstract ORCID
53.96 11
34 Environmental challenges in hemodialysis: Exploring the road… (10.1016/j.nefroe.2024.11.021)
Abstract ORCID
53.96 11
35 Erratum to “Spanish Clinical Guidelines on Vascular Access f… (10.1016/j.nefroe.2018.07.006)
Abstract References ORCID
52.42 4
36 Acute kidney injury secondary to a combination of renin-angi… (10.1016/j.nefroe.2015.05.010)
Abstract ORCID
52.07 10
37 Cystinosis in adult and adolescent patients: Recommendations… (10.1016/j.nefroe.2015.06.010)
Abstract ORCID
52.07 10
38 Musculoskeletal pain in patients with chronic kidney disease (10.1016/j.nefroe.2016.10.005)
Abstract ORCID
52.07 10
39 High temperatures and nephrology: The climate change problem (10.1016/j.nefroe.2016.12.015)
Abstract ORCID
52.07 10
40 Plant phosphates, phytate and pathological calcifications in… (10.1016/j.nefroe.2017.01.018)
Abstract ORCID
52.07 10
41 Role of pyrophosphate in vascular calcification in chronic k… (10.1016/j.nefroe.2018.03.003)
Abstract ORCID
52.07 10
42 Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios a… (10.1016/j.nefroe.2018.11.013)
Abstract ORCID
52.07 10
43 Spanish Registry of glomerulonephritis 2020 revisited: past,… (10.1016/j.nefroe.2020.08.004)
Abstract ORCID
52.07 10
44 Kidney transplant outcome of expanded criteria donors after… (10.1016/j.nefroe.2021.01.005)
Abstract ORCID
52.07 10
45 Mineralcorticoid receptor blockers in chronic kidney disease (10.1016/j.nefroe.2021.08.001)
Abstract ORCID
52.07 10
46 Frailty and kidney transplant candidates (10.1016/j.nefroe.2021.08.003)
Abstract ORCID
52.07 10
47 Towards zero liquid discharge in hemodialysis. Possible issu… (10.1016/j.nefroe.2022.01.001)
Abstract ORCID
52.07 10
48 Evolution of kidney allograft loss causes over 40 years (197… (10.1016/j.nefroe.2023.07.003)
Abstract ORCID
52.07 10
49 Osteoporosis management in patients with chronic kidney dise… (10.1016/j.nefroe.2024.03.005)
Abstract ORCID
52.07 10
50 Spanish Clinical Guidelines on Vascular Access for Haemodial… (10.1016/s2013-2514(19)30100-2)
Abstract ORCID
52.07 10